Title of article
Alendronate reduces the daily consumption of insulin (DCI) in patients with senile type I diabetes and osteoporosis
Author/Authors
Maugeri، نويسنده , , D. and Panebianco، نويسنده , , P. H. Rosso، نويسنده , , D. and Calanna، نويسنده , , A. and Speciale، نويسنده , , S. and Santangelo، نويسنده , , A. and Rizza، نويسنده , , I. and Motta، نويسنده , , M. and Lentini، نويسنده , , A. and Malaguarnera، نويسنده , , M.، نويسنده ,
Issue Information
روزنامه با شماره پیاپی سال 2002
Pages
6
From page
117
To page
122
Abstract
The use of Alendronate for the treatment of senile diabetes with osteopenia or osteoporosis is a common practice today, although the reasons for the success of this treatment are not completely understood. We investigated 40 elderly female patients, over
Keywords
ALENDRONATE , Senile type I diabetes , Daily consumption of insulin , Osteoporosis
Journal title
Archives of Gerontology and Geriatrics
Serial Year
2002
Journal title
Archives of Gerontology and Geriatrics
Record number
1764827
Link To Document